These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1747953)

  • 1. Restricted specificity of the autoantibody response in Goodpasture's syndrome demonstrated by two-dimensional western blotting.
    Derry CJ; Dunn MJ; Rees AJ; Pusey CD
    Clin Exp Immunol; 1991 Dec; 86(3):457-63. PubMed ID: 1747953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane.
    Pusey CD; Dash A; Kershaw MJ; Morgan A; Reilly A; Rees AJ; Lockwood CM
    Lab Invest; 1987 Jan; 56(1):23-31. PubMed ID: 3540450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of T cell responses to the autoantigen in Goodpasture's disease.
    Derry CJ; Ross CN; Lombardi G; Mason PD; Rees AJ; Lechler RI; Pusey CD
    Clin Exp Immunol; 1995 May; 100(2):262-8. PubMed ID: 7743665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific distribution of the Goodpasture antigen demonstrated by 2-D electrophoresis and western blotting.
    Derry CJ; Pusey CD
    Nephrol Dial Transplant; 1994; 9(4):355-61. PubMed ID: 8084446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the Goodpasture antigen, alpha 3(IV) NC1, and four other NC1 domains of type IV collagen, by amino-terminal sequence analysis of human glomerular basement membrane separated by two-dimensional electrophoresis.
    Derry CJ; Pickering M; Baker C; Pusey CD
    Exp Nephrol; 1994; 2(4):249-56. PubMed ID: 7520821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of autoantibodies from patients with Goodpasture's disease using a resonant mirror biosensor.
    Dougan T; Levy JB; Salama A; George AJ; Pusey CD
    Clin Exp Immunol; 2002 Jun; 128(3):555-61. PubMed ID: 12067312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome.
    Hellmark T; Johansson C; Wieslander J
    Kidney Int; 1994 Sep; 46(3):823-9. PubMed ID: 7527877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The non-collagenous domains of the alpha 3 and 4 chains of type IV collagen and their relationship to the Goodpasture antigen.
    Savige JA; Gallicchio M
    Clin Exp Immunol; 1991 Jun; 84(3):454-8. PubMed ID: 2044225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition.
    Ryan JJ; Mason PJ; Pusey CD; Turner N
    Clin Exp Immunol; 1998 Jul; 113(1):17-27. PubMed ID: 9697978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of EHS type IV collagen lacking Goodpasture's epitope in glomerulonephritis in rats.
    Bolton WK; Luo AM; Fox PL; May WJ; Sturgill BC
    Kidney Int; 1995 Feb; 47(2):404-10. PubMed ID: 7536854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Goodpasture's disease: a report of ten cases and a review of the literature.
    Dammacco F; Battaglia S; Gesualdo L; Racanelli V
    Autoimmun Rev; 2013 Sep; 12(11):1101-8. PubMed ID: 23806563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.
    Cui Z; Zhao MH; Jia XY; Wang M; Hu SY; Wang SX; Yu F; Brown KL; Hudson BG; Pedchenko V
    J Autoimmun; 2016 Jun; 70():1-11. PubMed ID: 27117167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in the NC1 domain of collagen type IV in GBM in canine hereditary nephritis.
    Thorner P; Baumal R; Valli VE; Mahuran D; McInnes R; Marrano P
    Kidney Int; 1989 Mar; 35(3):843-50. PubMed ID: 2651761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and characterization of recombinant rat alpha 3(IV)NC1 and its use in induction of experimental autoimmune glomerulonephritis.
    Ryan JJ; Reynolds J; Norgan VA; Pusey CD
    Nephrol Dial Transplant; 2001 Feb; 16(2):253-61. PubMed ID: 11158397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Analysis of Goodpasture's Disease Following Hematopoietic Stem Cell Transplant in a Pediatric Patient, Recalls the Conformeropathy of Wild-Type Anti-GBM Disease.
    Gray PE; McCarthy H; Siggs OM; Saleem MA; O' Brien T; Frith K; Ziegler JB; Kitching AR; Fogo AB; Hudson BG; Pedchenko V
    Front Immunol; 2019; 10():2659. PubMed ID: 31798588
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of a non-Goodpasture autoantibody to type IV collagen.
    Johansson C; Butkowski R; Swedenborg P; Alm P; Wieslander J
    Nephrol Dial Transplant; 1993; 8(11):1205-10. PubMed ID: 8302456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and application of an ELISA for Goodpasture's disease based on sheep alpha 3(IV)NC1 domains.
    Katbamna I; Turner N; Ross CN; Pusey CD
    J Clin Lab Immunol; 1995; 47(1):11-24. PubMed ID: 8735432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
    Brainwood D; Kashtan C; Gubler MC; Turner AN
    Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of kidney-bound antibodies in Goodpasture's syndrome.
    Saxena R; Bygren P; Butkowski R; Wieslander J
    Clin Exp Immunol; 1989 Oct; 78(1):31-6. PubMed ID: 2805421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.